InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by JOHNSON KENNETH ERLAND. Insider active across 2 companies, notably Xeris Pharmaceuticals INC. In total, 6 reports have been logged. The latest transaction was filed on 3 January 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
075,000 shares0
Common Stock
SEC:0001867096-22-000010·
075,000 shares0
Common Stock
SEC:0001867096-22-000010:0·
11,250 shares
Common Stock
SEC:0000899243-21-039246·
11,250 shares
Common Stock
SEC:0000899243-21-039319·
11,250 shares
Common Stock
SEC:0000899243-21-039246:0·
11,250 shares
Common Stock
SEC:0000899243-21-039319:0·
6 of 6 declarations
About JOHNSON KENNETH ERLAND
Kenneth Erland Johnson is a director at Xeris Pharmaceuticals INC and Xeris Biopharma Holdings, Inc.
